Ownership

Luke Walker - Insider Trading & Ownership

Entity: Individual
Location: C/O Cascadian Therapeutics, Inc., 3101 Western Ave., Suite 600, Seattle, WA
Summary: The estimated net worth of Luke Walker is at least $152K dollars as of February 4, 2025. Luke Walker is the Director of Zentalis Pharmaceuticals, Inc. and owns shares of Zentalis Pharmaceuticals, Inc. (ZNTL) stock worth about $152K.
All Insider Reports: All Insider Reports

Ownership of Luke Walker

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
ZNTL	Zentalis Pharmaceuticals, Inc.	Director	$152K	+$25K	+19.6%	Jan 31, 2025
HARP	Harpoon Therapeutics, Inc.	Chief Medical Officer	$0			Mar 11, 2024
CNTX	Context Therapeutics Inc.	Director				Sep 4, 2024

Insider Transactions Reported by Luke Walker:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.